The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. Authors marked with an asterisk (*) are participants in ASCO’s Disclosure Management System Pilot; their disclosure is not limited to subject matter under consideration in this article and includes payments to themselves, an immediate family member (I), and/or their institutions (Inst). For information on the pilot program, or to provide feedback, please visit coipilot.asco.org. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Analysis of outcomes of patients (pts) with blastic plasmacytoid dendritic cell neoplasm (BPDCN).
Naveen Pemmaraju
No relevant relationships to disclose
Deborah A. Thomas
No relevant relationships to disclose
* Hagop Kantarjian
No relevant relationships to disclose
Susan Mary O'Brien
No relevant relationships to disclose
Naval Guastad Daver
No relevant relationships to disclose
Aziz Nazha
No relevant relationships to disclose
Sherry Pierce
No relevant relationships to disclose
Guillermo Garcia-Manero
No relevant relationships to disclose
Jorge E. Cortes
No relevant relationships to disclose
Stefan Faderl
No relevant relationships to disclose